⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1414022 | 0.97 | POLB (0.41) | — | |
| SCHEMBL1460 | 0.97 | — | — | |
| SCHEMBL28302405 | 0.95 | — | — | |
| Fluoride SCHEMBL28204776 | 0.95 | — | — | |
| SCHEMBL28094435 | 0.95 | — | — | |
| Hydrogen Sulfide SCHEMBL28847244 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL865815 | 0.95 | — | — | |
| Bromide SCHEMBL30767150 | 0.95 | — | — | |
| SCHEMBL7569502 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL10435844 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2804607-B1 | SYNTHESIS OF RALTEGRAVIR | EMCURE PHARMACEUTICALS LTD (IN) | 2020-09-16 | — | — | EP | disclosed |
| US-20160311810-A1 | SYNTHESIS OF RALTEGRAVIR | EMCURE PHARMACEUTICALS LTD (IN) | 2016-10-27 | — | — | US | disclosed |
| US-9475799-B1 | Synthesis of Raltegravir | EMCURE PHARMACEUTICALS LIMITED (IN) | 2016-10-25 | — | — | US | disclosed |
| US-9403809-B2 | Synthesis of raltegravir | EMCURE PHARMACEUTICALS LIMITED (IN) | 2016-08-02 | — | — | US | disclosed |
| US-20150045554-A1 | SYNTHESIS OF RALTEGRAVIR | EMCURE PHARMACEUTICALS LIMITED (IN) | 2015-02-12 | — | — | US | disclosed |
| EP-2804607-A2 | SYNTHESIS OF RALTEGRAVIR | Emcure Pharmaceuticals Limited (IN) | 2014-11-26 | — | — | EP | disclosed |
| WO-2013098854-A2 | SYNTHESIS OF RALTEGRAVIR | EMCURE PHARMACEUTICALS LIMITED (IN) | 2013-07-04 | — | — | WO | disclosed |
| US-8097619-B2 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | AGENNIX USA INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-7893057-B2 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | AGENNIX USA INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-7786112-B2 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | AGENNIX USA INC. (US) | 2010-08-31 | — | — | US | disclosed |
| EP-1228070-A1 | HETEROALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2002-08-07 | — | — | EP | disclosed |
| EP-1226144-A1 | ALKYLAMINO SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-31 | — | — | EP | disclosed |
| EP-1178970-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRYMIDINONES USEFUL AS ANTICOAGULANTS | Pharmacia Corporation (US) | 2002-02-13 | — | — | EP | disclosed |
| US-20020013328-A1 | 6-Substituted pyrazolo[3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-01-31 | — | — | US | disclosed |
| WO-2001087851-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-11-22 | — | — | WO | disclosed |
| EP-1121363-A2 | 6-SUBSTITUTED PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2001-08-08 | — | — | EP | disclosed |
| WO-2001029042-A1 | HETEROALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001029041-A1 | ALKYLAMINO SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |
| WO-2000069832-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRYMIDINONES USEFUL AS ANTICOAGULANTS | PHARMACIA CORPORATION (US) | 2000-11-23 | — | — | WO | disclosed |
| WO-2000021926-A2 | 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-04-20 | — | — | WO | disclosed |